3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Carcinoma, Hepatocellular
46
Colorectal Neoplasms
33
Stomach Neoplasms
31
Esophageal Squamous Cell Carcinoma
27
Esophageal Neoplasms
14
Rectal Neoplasms
12
Cholangiocarcinoma
11
Colonic Neoplasms
9
Pancreatic Neoplasms
7
Neoplasm Metastasis
6
Sarcoma
5
Carcinoma, Non-Small-Cell Lung
5
Locally Advanced Rectal Cancer
4
Biliary Tract Neoplasms
4
Triple Negative Breast Neoplasms
3
Small Cell Lung Carcinoma
3
Recurrence
3
Melanoma
3
Liver Neoplasms
3
Carcinoma, Renal Cell
3
Carcinoma
3
Adenocarcinoma Of Esophagus
3
Uterine Cervical Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Neoplasms
2
Mesothelioma
2
Lung Neoplasms
2
HER2-positive Gastric Cancer
2
Endometrial Neoplasms
2
Digestive System Neoplasms
2
Interventions
Cryotherapy
2
Cisplatin
2
tislelizumab
1
epigallocatechin gallate
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy
1
Radiation
1
Gastropexy
1
Fundoplication
1
Fluorouracil
1
Esophagoscopy
1
Esophagectomy
1
Endoscopy, Digestive System
1
Cryoelectron Microscopy
1
Carboplatin
1
Brachytherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Deglutition Disorders
×
tislelizumab
×
Gastrointestinal
×
Clear all
NCT05596890
2022-11-28
PICCRT
Guangdong Provincial People's Hospital
Phase 2
Unknown
50 enrolled